Linaclotide + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Functional Constipation
Conditions
Functional Constipation
Trial Timeline
Apr 27, 2023 → Jun 9, 2025
NCT ID
NCT05760313About Linaclotide + Placebo
Linaclotide + Placebo is a phase 2 stage product being developed by AbbVie for Functional Constipation. The current trial status is completed. This product is registered under clinical trial identifier NCT05760313. Target conditions include Functional Constipation.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05760313 | Phase 2 | Completed |
| NCT04026113 | Phase 3 | Completed |
Competing Products
20 competing products in Functional Constipation